'Positive breast cancer' presentation slideshows

Objectives

Objectives. Adjuvant tamoxifen duration ( S1-2) Adjuvant trastuzumab duration ( S5-2) Adjuvant chemotherapy for isolated local regional recurrence ( S3-2) Role of bevacizumab ? ( S1-7, S6-5).

778 views • 64 slides

Moving from Correlative Science to Predictive Medicine

Moving from Correlative Science to Predictive Medicine. Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute http://linus.nci.nih.gov/brb. BRB Website brb.nci.nih.gov. Powerpoint presentations and audio files Reprints & Technical Reports BRB-ArrayTools software

804 views • 61 slides

NCT00688740 Sponsored by sanofi-aventis

Ten-year follow-up analysis of the BCIRG 001 trial confirms superior DFS and OS benefit of adjuvant TAC ( docetaxel , doxorubicin, cyclophosphamide ) over FAC (fluorouracil, doxorubicin, cyclophosphamide ) in women with operable node-positive breast cancer.

433 views • 26 slides

Highlights in the Management of Breast Cancer Rome, May 25-26, 2007

935 views • 20 slides

Drugs In

Drugs In. OVULATION INDUCTION. Drugs In. OVULATION INDUCTION. ILOs. By the end of this lecture you will be able to: Recall how ovulation occurs and specify its hormonal regulation Classify ovulation inducing drugs in relevance to the existing deficits

502 views • 17 slides

Drugs In

Drugs In. OVULATION INDUCTION. Drugs In. OVULATION INDUCTION. ILOs. By the end of this lecture you will be able to: Recall how ovulation occurs and specify its hormonal regulation Classify ovulation inducing drugs in relevance to the existing deficits

528 views • 16 slides